Balkis Meddeb

1.6k total citations · 1 hit paper
50 papers, 1.0k citations indexed

About

Balkis Meddeb is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Balkis Meddeb has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 16 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Balkis Meddeb's work include Platelet Disorders and Treatments (17 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Acute Myeloid Leukemia Research (10 papers). Balkis Meddeb is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Acute Myeloid Leukemia Research (10 papers). Balkis Meddeb collaborates with scholars based in Tunisia, United States and France. Balkis Meddeb's co-authors include Mansoor N. Saleh, James B. Bussel, Gregory Cheng, Nicole L. Stone, Bhabita Mayer, Lidia Kovaleva, J.M. Jenkins, Drew Provan, Bethan Psaila and Janusz Kłoczko and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Balkis Meddeb

46 papers receiving 970 citations

Hit Papers

Eltrombopag for the Treatment of Chronic Idiopathic Throm... 2007 2026 2013 2019 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
    2007 565 citations James B. Bussel, Gregory Cheng et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Balkis Meddeb Tunisia 13 774 241 189 135 119 50 1.0k
Peter A.W. te Boekhorst Netherlands 21 582 0.8× 245 1.0× 97 0.5× 51 0.4× 221 1.9× 50 1.1k
Mario Annunziata Italy 17 592 0.8× 255 1.1× 65 0.3× 48 0.4× 202 1.7× 51 776
Abraham Kornberg Israel 17 346 0.4× 106 0.4× 75 0.4× 88 0.7× 189 1.6× 54 925
Junji Tomiyama Japan 13 235 0.3× 100 0.4× 91 0.5× 83 0.6× 110 0.9× 47 565
Renate Thalhammer Austria 14 393 0.5× 199 0.8× 88 0.5× 84 0.6× 181 1.5× 35 1.0k
Christopher Enny United States 14 425 0.5× 255 1.1× 178 0.9× 32 0.2× 330 2.8× 21 962
Nicholas Wickham Australia 16 292 0.4× 174 0.7× 105 0.6× 45 0.3× 256 2.2× 35 804
Hawk Kim South Korea 22 882 1.1× 340 1.4× 256 1.4× 157 1.2× 342 2.9× 111 1.5k
Burhan Ferhanoğlu Türkiye 14 212 0.3× 262 1.1× 505 2.7× 94 0.7× 109 0.9× 78 1.1k
Nicole A. Carreau United States 9 410 0.5× 150 0.6× 36 0.2× 55 0.4× 157 1.3× 12 677

Countries citing papers authored by Balkis Meddeb

Since Specialization
Citations

This map shows the geographic impact of Balkis Meddeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balkis Meddeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balkis Meddeb more than expected).

Fields of papers citing papers by Balkis Meddeb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Balkis Meddeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balkis Meddeb. The network helps show where Balkis Meddeb may publish in the future.

Co-authorship network of co-authors of Balkis Meddeb

This figure shows the co-authorship network connecting the top 25 collaborators of Balkis Meddeb. A scholar is included among the top collaborators of Balkis Meddeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Balkis Meddeb. Balkis Meddeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michallet, Anne‐Sophie, Melih Aktan, Wolfgang Hiddemann, et al.. (2018). Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study. Haematologica. 103(4). 698–706. 50 indexed citations
2.
Bellâaj, Hatem, Yosra Ben Youssef, Amel Lakhal, et al.. (2018). Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience). Annals of Hematology. 97(4). 597–604. 5 indexed citations
3.
Amouri, Ahlem, et al.. (2015). Leukemia in Patients with Klinefelter Syndrome: A Report of Two Cases. Indian Journal of Hematology and Blood Transfusion. 32(S1). 66–68. 3 indexed citations
4.
Khodjet‐El‐Khil, Houssein, et al.. (2012). First report of molecular diagnosis of Tunisian hemophiliacs A: Identification of 8 novel causative mutations. Diagnostic Pathology. 7(1). 93–93. 10 indexed citations
5.
6.
Meddeb, Balkis, et al.. (2011). Factor VIII haplotypes frequencies in Tunisian hemophiliacs A. Diagnostic Pathology. 6(1). 54–54. 6 indexed citations
7.
Youssef, Yosra Ben, Imed Harrabi, Balkis Meddeb, et al.. (2011). Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients. Medical Oncology. 29(2). 1151–1160. 2 indexed citations
8.
Jeddi, Ramzi, et al.. (2010). Recurrent differentiation syndrome or septic shock? Unresolved dilemma in a patient with acute promyelocytic leukemia. Medical Oncology. 28(1). 279–281. 3 indexed citations
9.
10.
11.
Beaufils, Nathalie, et al.. (2010). E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib. Journal of Clinical Pathology. 63(8). 737–740. 11 indexed citations
12.
Jeddi, Ramzi, et al.. (2009). High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia. Leukemia Research. 34(4). 545–547. 24 indexed citations
13.
Jeddi, Ramzi, et al.. (2008). Secondary chronic myelomonocytic leukemia with monosomy 7 after successful treatment of acute promyelocytic leukemia. Pathologie Biologie. 56(3). 162–163. 4 indexed citations
14.
Meyer, Sara C., Ramzi Jeddi, Balkis Meddeb, et al.. (2008). A first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13. Annals of Hematology. 87(8). 663–666. 22 indexed citations
15.
16.
Jeddi, Ramzi, et al.. (2007). Predictive factors of septic shock and mortality in neutropenic patients. Hematology. 12(6). 543–548. 27 indexed citations
17.
Bussel, James B., Gregory Cheng, Mansoor N. Saleh, et al.. (2007). Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura. New England Journal of Medicine. 357(22). 2237–2247. 565 indexed citations breakdown →
18.
Gouider, Emna, et al.. (2007). [Hemoglobin C disease: report of 16 Tunisian cases].. PubMed. 85(3). 209–11. 2 indexed citations
19.
Palomar, Amaya Pérez del, et al.. (2002). Oxygen-Induced Inhibition of Vascular Endothelial Cell and Retinal Astrocyte Development is Age-Dependent in Mice. Investigative Ophthalmology & Visual Science. 43(13). 1284–1284. 1 indexed citations
20.
Schots, Rik, Fabienne Trullemans, Ivan Van Riet, et al.. (2000). THE CLINICAL IMPACT OF EARLY GRAM-POSITIVE BACTEREMIA AND THE USE OF VANCOMYCIN AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION. Transplantation. 69(7). 1511–1514. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter A.W. te Boekhorst Breakdown of academic impact, for papers by Mario Annunziata Breakdown of academic impact, for papers by Abraham Kornberg Breakdown of academic impact, for papers by Junji Tomiyama Breakdown of academic impact, for papers by Renate Thalhammer Breakdown of academic impact, for papers by Christopher Enny Breakdown of academic impact, for papers by Nicholas Wickham Breakdown of academic impact, for papers by Hawk Kim Breakdown of academic impact, for papers by Burhan Ferhanoğlu Breakdown of academic impact, for papers by Nicole A. Carreau
Rankless by CCL
2026